Revised SPC: Enstilar (calcipotriol/betamethasone) Cutaneous Foam

SPC now advises those who responded to 4 weeks’ of once daily treatment are suitable for long-term maintenance treatment involving twice weekly application on 2 non-consecutive days to previously affected areas; and between applications there should be 2-3 days without treatment.

Source:

electronic Medicines compendium